New! ProFound AI for DBT v3.0
The Clear Leader in Breast AI.
FDA Cleared, CE Mark Pending
ProFound AI for 2D Mammography
World-class artificial intelligence for 2D mammography
CE Mark Approved, not available for sale in the United States
<
>
About iCAD
iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
iCAD Technology Innovation Day Webinar – Expanded ProFound AI Portfolio
Featuring presentations by Key Opinion Leaders who discuss the current landscape for digital breast tomosynthesis (DBT) and the potential for iCAD's recently introduced ProFound AI Risk, the first and only commercially available clinical decision support tool that provides an accurate two-year breast cancer risk estimation based solely on a screening mammogram.
From the Newsroom
April 28, 2021
iCAD Reports Financial Results for the First Quarter Ended March 31, 2021April 20, 2021
iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28April 19, 2021
New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ WorkflowApril 05, 2021
iCAD Announces Estimated Q1 Revenues and Upcoming CFO TransitionMarch 31, 2021
New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates
» View all news »
Discover the Power of ProFound AI® for Digital Breast Tomosynthesis
Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care. ProFound AI® is clinically proven to assist radiologists by improving cancer detection, decreasing reading times and reducing false positives and costly patient recalls.
iNFORMED - BlogInform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.View BlogMedia SpotlightThe New Normal - The Imaging Landscape in Late-Stage Pandemic DaysView ArticleClinical FeatureImproving reading time of digital breast tomosynthesis with concurrent computer aided detection.View White Paper
Supporting cancer detection for 3,500+ healthcare facilities worldwide
Speak to a specialist today at 1.866.280.2239
Resources
Precise and Powerful Healthcare Solutions
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.